Severe Complications in Testicular Germ Cell Tumors: The Choriocarcinoma Syndrome
2019 · Frontiers in Endocrinology · 44 citations
https://doi.org/10.3389/fendo.2019.00218
M
Maria Concetta Cursano
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori(IT)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
54
Papers
601
Citations
12
h-index
12
i10-index
Maria Concetta Cursano is an academic researcher from Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori. The author has contributed to research in topics: Prostate Cancer Treatment and Research & Radiopharmaceutical Chemistry and Applications & Bone health and treatments. The author has an h-index of 12, co-authored 46 publications.
ORCID: 0000-0001-5064-3950Papers by this author
worksEfficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2−) advanced breast cancer patients: New insights beyond clinical trials. The EVA study
2017 · The Breast · 23 citations
https://doi.org/10.1016/j.breast.2017.06.043
Bone metastases from urothelial carcinoma. The dark side of the moon
2021 · Journal of bone oncology · 22 citations
https://doi.org/10.1016/j.jbo.2021.100405
Grade group system and plasma androgen receptor status in the first line treatment for metastatic castration resistant prostate cancer
2022 · Scientific Reports · 4 citations
https://doi.org/10.1038/s41598-022-10751-6
Endometriosis and endometrial cancer: A propensity score-adjusted real-world data study
2024 · iScience · 3 citations
https://doi.org/10.1016/j.isci.2024.109680
Over 17-month complete clinical brain response with a well-tolerated lapatinib plus capecitabine combination in a very young patient afflicted by HER2-positive metastatic breast cancer.
2014 · PubMed · 0 citations
https://doi.org/10.1700/1390.15467
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat